Actively Recruiting
A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
Led by Jiangsu HengRui Medicine Co., Ltd. · Updated on 2026-02-18
240
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.
CONDITIONS
Official Title
A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to provide a written informed consent.
- Subjects requiring elective general anesthesia surgery.
- Male or female.
- Meet the weight standard.
You will not qualify if you...
- Pediatric patients scheduled for elective cardiothoracic, neurosurgical, or hepatic surgery.
- Patients planned to receive anesthetic techniques other than total intravenous anesthesia (TIVA) during surgery.
- Patients with medical history or evidence increasing sedation or anesthesia risk deemed unsuitable by the investigator.
- Patients with history of asthma or risk for difficult mask ventilation or intubation.
- Patients with clinically significant abnormal laboratory test values.
- Known intolerance or allergy to benzodiazepines, propofol, opioids, neuromuscular blocking agents, or components.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
L
Lei Tang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here